The Motley Fool·Feb 13·Daniel SparksPalantir Stock Faces Valuation Concerns Despite Strong Financial PerformancePalantir posts strong 70% revenue growth and 250% net income surge, but sky-high valuation metrics leave little room for any growth slowdown. PLTRvaluationprofitability
Benzinga·Feb 13·PrnewswireNASDAQ-Listed Charming Medical Faces Class Action Over Stock Promotion SchemeClass action filed against Charming Medical for alleged stock price manipulation through coordinated social media promotion. Trading suspended pending SEC investigation. MCTAsecurities fraudclass action lawsuit
The Motley Fool·Feb 13·Eric VolkmanTesla Stock Faces Valuation Pressure Amid Pivot to Unproven VenturesTesla stock down 5% YTD after missing Q4 targets with 16% delivery decline. Company pivots to unproven autonomous and robotics ventures amid high valuation pressures. TSLAvaluation concernsOptimus robot
GlobeNewswire Inc.·Feb 13·NaTilray Expands UK Pharma Distribution Through Smartway PartnershipTilray Pharma partners with Smartway Pharmaceuticals to expand UK drug distribution, combining their networks to strengthen presence in Britain's £1 billion pharma market. TLRYsupply chainstrategic partnership
GlobeNewswire Inc.·Feb 13·NaTilray Expands UK Pharmaceutical Distribution Through CC Pharma PartnershipTilray expands UK pharmaceutical distribution via CC Pharma's partnership with Smartway Pharmaceuticals, combining distribution networks and manufacturing expertise to serve the £1 billion market. TLRYsupply chainstrategic partnership
GlobeNewswire Inc.·Feb 13·Okyo Pharma LimitedOKYO Pharma Prices $20M Share Offering to Fund Clinical DevelopmentOKYO Pharma prices $20M share offering to fund clinical development of urcosimod for neuropathic corneal pain treatment, advancing Phase 2b/3 trial. OKYOPIPRclinical developmentpublic offering
GlobeNewswire Inc.·Feb 13·Rosen Law FirmUltragenyx Investors Face April Deadline in Securities Litigation Over Setrusumab ClaimsUltragenyx faces securities lawsuit alleging misleading claims about setrusumab's efficacy. Investors must act by April 6, 2026 deadline to join class action. RAREsecurities fraudclass action lawsuit
GlobeNewswire Inc.·Feb 13·Vci Global LimitedVCI Global Advances AI-Native Strategy With Subsidiary IPO FilingVCI Global files subsidiary IPO to advance AI-native strategy. V Capital Consulting seeks Nasdaq listing as parent company pivots to AI-focused operations. VCIGcapital allocationNasdaq compliance
GlobeNewswire Inc.·Feb 13·Vci Global LimitedVCI Global Pursues AI-Native Strategy as Subsidiary Eyes Nasdaq ListingVCI Global pursues AI-native strategy while spinning off consulting subsidiary VCCG, which filed for Nasdaq listing. Parent company focuses on robotics, clean energy, and automotive technologies. VCIGoperational efficiencyNasdaq compliance
The Motley Fool·Feb 13·Stefon WaltersTwo Tech Leaders Emerge as Long-Term Holdings for Growth InvestorsAmazon and CrowdStrike identified as strong long-term tech investments. Amazon dominates cloud computing; CrowdStrike leads in AI-driven cybersecurity solutions. MSFTAMZNGOOGGOOGLCRWDcloud computingAWS
GlobeNewswire Inc.·Feb 13·NaCoherus Oncology Raises $50.1M Through Common Stock OfferingCoherus Oncology raises $50.1M via stock offering to fund commercial expansion of LOQTORZI and advance oncology pipeline development programs. CHRSclinical developmentpublic offering
The Motley Fool·Feb 13·Neil PatelChipotle Maps Path to $28B Revenue Target Through Expansion and Unit EconomicsChipotle plans to nearly double restaurants to 7,000 locations, targeting $28B revenue through expansion and improved unit economics while maintaining strong profit margins. SBUXCMGvaluation opportunityrestaurant expansion
Benzinga·Feb 13·PrnewswireAmerican Homes 4 Rent Raises Quarterly Payout to $0.33 Per ShareAmerican Homes 4 Rent raises quarterly dividend to $0.33 per share, a 10% increase from $0.30, payable March 31, 2026. AMHAMHpGAMHpHdividend increaseshareholder returns
Benzinga·Feb 13·PrnewswireHot Chili Secures A$40M Funding Round to Advance Chilean Copper-Gold OperationsHot Chili raises A$40M to advance its Chilean copper-gold Costa Fuego project, with backing from major investors including Glencore. Funds will support environmental assessments and La Verde integration. GLNCYinstitutional investorsprivate placement
GlobeNewswire Inc.·Feb 13·Rosen Law FirmSLM Investors Urged to Meet February Deadline in Securities LitigationSLM Corporation faces securities lawsuit over allegedly false statements about loan delinquencies. Investors have until February 17, 2026 to file lead plaintiff claims. SLMSLMBPsecurities class actionlead plaintiff deadline
GlobeNewswire Inc.·Feb 13·Rosen Law FirmSDM Investors Face March Deadline in Securities Fraud Class ActionSDM investors face March 16, 2026 deadline to join securities fraud class action alleging material misrepresentations and market manipulation scheme. SDMsecurities class actionlead plaintiff deadline
The Motley Fool·Feb 13·Geoffrey SeilerSanDisk Valuation Pullback Reflects Market Opportunity in Memory ShortageSanDisk dropped 14% from February peak but strong fundamentals—61% revenue growth, expanding margins—suggest pullback may offer buying opportunity amid AI-driven memory shortage. SNDKWDCsemiconductor shortageAI data centers
The Motley Fool·Feb 13·Joe TenebrusoFastly Shares Surge on Strong Q4 Results and AI Growth OutlookFastly shares surge 72% after beating Q4 expectations with strong revenue growth and AI infrastructure demand. Company projects 14% revenue growth in 2026 driven by AI workloads. FSLYagentic AIrevenue growth
Benzinga·Feb 13·PrnewswireWeyerhaeuser Maintains Dividend Policy With $0.21 Per Share PayoutWeyerhaeuser maintains quarterly dividend of $0.21 per share, reflecting its commitment to returning 75-80% of annual distributable funds to shareholders. WYquarterly dividendshareholder returns
The Motley Fool·Feb 13·Danny Vena, CpaDutch Bros Posts 29% Revenue Growth, Eyes Further Expansion in 2026Dutch Bros Coffee posts 29% revenue growth and 143% EPS surge in Q4 2025. Company opens 55 new locations, projects 23% growth for 2026. BROSSBUXexpansionvaluation